Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subject: MRR

Patch-based Wound Healing Market Size to Grow by USD 329.13 million, Evolving Opportunities with 3M Co. and B. Braun SE - Technavio


NEW YORK, Sept. 13, 2022 /PRNewswire/ -- The patch-based wound healing market will be driven by factors such as the increasing demand for advanced wound healing products. Healing chronic wounds take a lot of time, and they are more expensive to treat. However, modern wound care solutions are highly effective and efficient. The demand for advanced wound care products is increasing owing to the rise in rate of chronic injuries. For example, alginates and silver-containing advanced wound care products are used for draining excess fluid from wounds and shielding them from infections. These products have chemicals that can lead to quick healing and encourage cell proliferation.

The patch-based wound healing market size is expected to grow by USD 329.13 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 4.8% during the forecast period.

Use the analysis and insights provided by Technavio for effective decision-making. Download a FREE PDF Sample Report

Market Challenges

Delayed diagnosis of advanced and chronic wounds is challenging the growth of the market. Delayed diagnosis and treatment can worsen chronic wounds. The rate of delayed diagnosis is generally higher in emerging countries such as Brazil, China, and India. This is due to a lack of regulations and action plans by governing authorities, inadequate access to well-developed healthcare infrastructure, and a lack of awareness among communities. These factors reduce diagnosis rates, which limits the adoption of patch-based wound healing products in emerging countries.

Key Vendors and their Offerings

3M Co., Advancis Medical, Axio Biosolutions Pvt Ltd, B. Braun SE, CliniMed Ltd, Coloplast AS, ConvaTec Group Plc, Essity Aktiebolag, Harro Hofliger GmbH, Healogics LLC, Integra Lifesciences Holdings Corp., Lohmann and Rauscher GmbH and Co. KG, Medipurpose Pvt. Ltd., Mediq, Medline Industries Inc., Medtronic Plc, Ostomed Ltd., Paul Hartmann AG, Richardson Healthcare Inc., Smith and Nephew plc, among others, are the main players in the market. The key offerings of a few of these vendors are listed below:

Get lifetime access to our Technavio Insights! Subscribe to our "Basic Plan" billed annually at USD 5000

Patch-based Wound Healing Market Application Outlook (Revenue, USD mn, 2021-2026)
Patch-based Wound Healing Market Geography Outlook (Revenue, USD mn, 2021-2026)

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report

Related Reports

Adhesion Barriers Market by Application, Product, and Geography - Forecast and Analysis 2022-2026

Wound Closure Devices Market by Product and Geography - Forecast and Analysis 2022-2026

Patch-based Wound Healing Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 4.8%

Market growth 2022-2026

USD 329.13 million

Market structure

Fragmented

YoY growth (%)

4.2

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 43%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

3M Co., Advancis Medical, Axio Biosolutions Pvt Ltd, B. Braun SE, CliniMed Ltd, Coloplast AS, ConvaTec Group Plc, Essity Aktiebolag, Harro Hofliger GmbH, Healogics LLC, Integra Lifesciences Holdings Corp., Lohmann and Rauscher GmbH and Co. KG, Medipurpose Pvt. Ltd., Mediq, Medline Industries Inc., Medtronic Plc, Ostomed Ltd., Paul Hartmann AG, Richardson Healthcare Inc., and Smith and Nephew plc

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Application

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 01:30
The global urinary catheters market  size is estimated to grow by USD 2.44 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 7.63%  during the forecast period. ...

at 00:25
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

19 mai 2024
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

19 mai 2024
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...



News published on and distributed by: